AI
Wednesday, March 03, 2010 11:42:28 AM
PTC/GENZ:
PTC Therapeutics and Genzyme Corporation Announce Preliminary Results from the Phase 2b Clinical Trial of Ataluren for Nonsense Mutation Duchenne/Becker Muscular Dystrophy
http://finance.yahoo.com/news/PTC-Therapeutics-and-Genzyme-bw-3208987972.html?x=0&.v=1
Basically study failed see the link for more detail. Genisi (or anyone else with a science background) care to speculate on what this means in other indications/their technology in general. I guess good thing they are still private or their stock would be down a lot today too
.
PTC Therapeutics and Genzyme Corporation Announce Preliminary Results from the Phase 2b Clinical Trial of Ataluren for Nonsense Mutation Duchenne/Becker Muscular Dystrophy
http://finance.yahoo.com/news/PTC-Therapeutics-and-Genzyme-bw-3208987972.html?x=0&.v=1
Basically study failed see the link for more detail. Genisi (or anyone else with a science background) care to speculate on what this means in other indications/their technology in general. I guess good thing they are still private or their stock would be down a lot today too
.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
